The regulatory domain of cannabis has been lately impacted by a number of international developments. Focusing particularly on the EU perspective, let us take/have a look at the most recent updates that have happened in the last six months.
News
Call for data on ingredients with potential endocrine-disrupting properties used in cosmetic products
Starting from February 15th, 2021, the European Commission launched a call for any interested parties to submit scientific information related to some cosmetic ingredients that may have potential endocrine-disrupting properties. Once the consultation period will be over, the European Commission will request an opinion to the EU Scientific Committee on Consumer Safety (SCCS) on this topic.
Copper nanoparticles: SCCS’ opinion raises concerns for safety
In March 2021, the Scientific Committee on Consumer Safety (SCCS) published the opinion on the use of nano copper and nano colloidal copper in cosmetics, informing that the data provided is insufficient to conclude that the use of these particles is safe.
COVID self-tests in Belgium: Conditions and approval process
From April 4, 2021, rapid antigen self-tests are allowed for sales in Belgian pharmacies! However, only if they respect strict conditions set out and verified by the Belgian Competent Authority FAMHP. Read more about it here!
The European privacy family & UK: towards an adequate level of personal data protection
The first step for the adoption of the adequacy decisions for transfers of personal data from the EU to the United Kingdom has been taken: the European Commission has published two draft decisions, one under the General Data Protection Regulation (GDPR) and the second one under the Law Enforcement Directive (LED).
Webinar: Software classification & compliance and MDR review process
In the webinar we provide an overview of MDR review process for Software, MDR Class I software, MDD Class I Software with class upgrade under MDR and more
COVID-19: France bans urine self-tests and opens the possibility for antigen self-tests
The French Competent Authority (ANSM) has prohibited the sale of antibody self-tests based on urine specimen, in view of its inefficacy and non-conformity with the EU requirements.
European preparedness and response to the COVID-19: a common list of rapid antigen tests
On January 2021, the Member States unanimously decided to settle a common framework covering the utilization of rapid antigen tests and the mutual recognition of COVID-19 test results within the European Community. Read more about it, here
EU Intellectual Property rights – are we covered in the UK?
From January 1, 2021, all EU Trade Marks (EUTM), Registered Community Designs (RCDs) and International Registrations designating will no longer provide protection in the United Kingdom.Read more about it here.
Logistical barriers due to Brexit and MDR
Many changes are occurring on the European continent concerning transport, import and distribution. The main reasons are the consequences of Brexit and the new Medical Device Regulation, that will become fully applicable on the 26th of May 2021.